Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes

Drug Metabolism and Disposition

Volumn 36, Issue 10, 2008, Pages 2086-2092

  Wolf, Kristina K ^a   Brouwer, Kenneth R ^b   Pollack, Gary M ^a   Brouwer, Kim L R ^a  

^a University of North Carolina   (United States)

^b Qualyst Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CALCIUM; DIGOXIN; FATTY ACID; PRAVASTATIN; TAUROCHOLIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG PROTEIN BINDING; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BILIARY TRACT; CHROMATOGRAPHY, LIQUID; DIGOXIN; HEPATOCYTES; LIVER; MALE; MICROSCOPY, FLUORESCENCE; PRAVASTATIN; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE; TANDEM MASS SPECTROMETRY; TAUROCHOLIC ACID;

BOVINAE; RATTUS;

EID: 52949124018     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.020842     Document Type: Article

References (48)

1. Annaert PP and Brouwer KLR (2005) Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes. Drug Metab Dispos 33:388-394.
2. Annaert PP, Turncliff RZ, Booth CL, Thakker DR, and Brouwer KLR (2001) P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metab Dispos 29:1277-1283.
3. Artursson P (1990) Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci 79:476-482.
4. Aungst BJ, Nguyen NH, Bulgarelli JP, and Oates-Lenz K (2000) The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharm Res 17:1175-1180.
5. Bennhold H (1965) Transport function of the serum proteins: historical review and report on recent investigations on the transport of dyestuffs and of iron, in Transport Functions of Plasma Proteins (Desgrez P and DeTraverse PM eds) pp 1-12, Elsevier Publishing Company, New York.
6. Bertucci C and Domenici E (2002) Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem 9:1463-1481.
7. Cross SE, Anissimov YG, Magnusson BM, and Roberts MS (2003) Bovine-serum-albumin-containing receptor phase better predicts transdermal absorption parameters for lipophilic compounds. J Invest Dermatol 120:589-591.
8. Cui Y, König J, Leier I, Buchholz U, and Keppler D (2001) Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276:9626-9630.
9. Fisher JM, Wrighton SA, Calamia JC, Shen DD, Kunze KL, and Thummel KE (1999) Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding. J Pharmacol Exp Ther 289:1143-1150.
10. Forker EL and Luxon BA (1981) Albumin helps mediate removal of taurocholate by rat liver. J Clin Invest 67:1517-1522.
11. Fukuda H, Ohashi R, Tsuda-Tsukimoto M, and Tamai I (2008) Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes. Drug Metab Dispos 36:1275-1282.
12. Hata S, Wang P, Eftychiou N, Ananthanarayanan M, Batta A, Salen G, Pang KS, and Wolkoff AW (2003) Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake. Am J Physiol Gastrointest Liver Physiol 285:G829-G839.
13. Hatanaka T (2000) Clinical pharmacokinetics of pravastatin - Mechanisms of pharmacokinetic events. Clin Pharmacokinet 39:397-412.
14. Hoffmaster KA, Turncliff RZ, LeCluyse EL, Kim RB, Meier PJ, and Brouwer KLR (2004) P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model of opioid peptide. Pharm Res 21:1294-1302.
15. Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, and Kirchgessner TG (1999) A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem 274:37161-37168.
16. Hung DY, Siebert GA, Chang P, and Roberts MS (2005) Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver. Br J Pharmacol 145:57-65.
17. Katneni K, Charman SA, and Porter CJH (2008) Use of plasma proteins as solubilizing agents in in vitro permeability experiments: correction for unbound drug concentration using the reciprocal permeability approach. J Pharm Sci 97:209-224.
18. Kemp DC, Zamek-Gliszczynski MJ, and Brouwer KLR (2005) Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes. Toxicol Sci 83:207-214.
19. Kragh-Hansen U, Chuang VT, and Otagiri M (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 25:695-704.
20. Krishna G, Chen K, Lin C, and Nomeir AA (2001) Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. Int J Pharm 222:77-89.
21. Lacy CF, Armstrong LL, Goldman MP, and Lance LL (2002) Digoxin, in Drug Information Handbook, 10th ed, pp 403-405, Lexi-Comp Inc., Hudson, OH.
22. LeCluyse EL, Audus KL, and Hochman JH (1994) Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am J Physiol 266:C1764-C1774.
23. LeCluyse EL, Bullock PL, Parkinson A, and Hochman JH (1996) Cultured rat hepatocytes. Pharm Biotechnol 8:121-159.
24. LeCluyse EL, Fix JA, Audus KL, and Hochman JH (2000) Regeneration and maintenance of bile canalicular networks in collagen-sandwiched hepatocytes. Toxicol In Vitro 14:117-132.
25. Liu L, Mak E, Tirona RG, Tan E, Novikoff PM, Wang P, Wolkoff AW, and Pang KS (2005) Vascular binding, blood flow, transporter, and enzyme interactions on the processing of digoxin in rat liver. J Pharmacol Exp Ther 315:433-448.
26. Liu X, Brouwer KLR, Gan LS, Brouwer KR, Stieger B, Meier PJ, Audus KL, and LeCluyse EL (1998) Partial maintenance of taurocholate uptake by adult rat hepatocytes cultured in a collagen sandwich configuration. Pharm Res 15:1533-1539.
27. Liu X, Chism JP, LeCluyse EL, Brouwer KR, and Brouwer KLR (1999a) Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos 27:637-644.
28. Liu X, LeCluyse EL, Brouwer KR, Gan LSL, Lemasters JJ, Stieger B, Meier PJ, and Brouwer KLR (1999b) Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am J Physiol 277:G12-G21.
29. McRae MP, Lowe CM, Tian X, Bourdet DL, Ho RH, Leake BF, Kim RB, Brouwer KLR, and Kashuba AD (2006) Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes. J Pharmacol Exp Ther 318:1068-1075.
30. Neuhoff S, Artursson P, Zamora I, and Ungell AL (2006) Impact of extracellular protein binding on passive and active drug transport across Caco-2 cells. Pharm Res 23:350-359.
31. Noé B, Hagenbuch B, Stieger B, and Meier PJ (1997) Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci U S A 94:10346-10350.
32. Otagiri M (2005) A molecular functional study on the interactions of drugs with plasma proteins. Drug Metab Pharmacokinet 20:309-323.
33. Oude Elferink RP, Meijer DK, Kuipers F, Jansen PL, Groen AK, and Groothuis GM (1995) Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta 1241:215-268.
34. Peters T Jr (1996) All About Albumin, Biochemistry, Genetics, and Medical Applications, Academic Press, Inc., San Diego.
35. Rowland A, Elliot DJ, Knights KM, Mackenzie PI, and Miners JO (2008a) The "albumin effect" and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhance phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9. Drug Metab Dispos 36:870-877.
36. Rowland A, Gaganis P, Elliot DJ, Mackenzie PI, Knights KM, and Miners JO (2007) Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolation. J Pharmacol Exp Ther 321:137-147.
37. Rowland A, Knights KM, Mackenzie PI, and Miners JO (2008b) The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities. Drug Metab Dispos 36:1056-1062.
38. Saha P and Kou JH (2002) Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers. Eur J Pharm Biopharm 54:319-324.
39. Sasaki M, Suzuki H, Aoki J, Ito K, Meier PJ, and Sugiyama Y (2004) Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2. Mol Pharm 66:450-459.
40. Seglen PO (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83.
41. Shi X, Bai S, Ford AC, Burk RD, Jacquemin E, Hagenbuch B, Meier PJ, and Wolkoff AW (1995) Stable inducible expression of a functional rat liver organic anion transport protein in HeLa cells. J Biol Chem 270:25591- 25595.
42. Shitara Y, Sugiyama D, Kusuhara H, Kato Y, Abe T, Meier PJ, Itoh T, and Sugiyama Y (2002) Comparative inhibitory effects of different compounds on rat Oatp1 (Slc21a1)- and Oatp2 (Slc21a5)-mediated transport. Pharm Res 19:147-153.
43. Taub ME, Kristensen L, and Frokjaer S (2002) Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Eur J Pharm Sci 15:331-340.
44. Tokui T, Nakai D, Nakagomi R, Yawo H, Abe T, and Sugiyama Y (1999) Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2. Pharm Res 16:904-908.
45. Turncliff RZ, Hoffmaster KA, Kalvass JC, Pollack GM, and Brouwer KLR (2006) Hepatobiliary disposition of a drug/metabolite pair: comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes. J Pharmacol Exp Ther 318:881-889.
46. Wilson G, Hassan IF, Dix CJ, Williamson I, Shah R, Mackay M, and Artursson P (1990) Transport and permeability properties of human Caco-2 cells: an in vitro model of the intestinal epithelial cell barrier. J Control Release 11:25-40.
47. Wiseman EH and Nelson E (1964) Correlation of in vitro metabolism rate and physical properties of sulfonamides. J Pharm Sci 53:992.
48. Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, and Tokuda H (2000) Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10:195-204.